{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:09:45Z","timestamp":1793459385867,"version":"4.5.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:list list-type=\"plain\">\n                      <jats:list-item>\n                        <jats:p>\u00bb A team approach among orthopaedic surgeons, infectious disease specialists, and patients is of paramount importance when treating periprosthetic joint infections (PJIs). Treatment usually includes various surgical approaches along with antibiotic treatment.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\u00bb Antibiotic selection requires a multifactorial decision that depends on the organism that is identified, its antibiotic-resistance profile, the extent of the infection, and factors associated with the host.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\u00bb Antibiotic duration is dependent on surgical intervention and the type of organism. Typically, patients are treated for 6 weeks after debridement, antibiotics, and implant retention (DAIR) and for 4 to 6 weeks after single-stage and 2-stage revision arthroplasty.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\u00bb Levofloxacin in combination with rifampin has shown favorable outcomes for Staphylococcus PJI treatment. Quinolones have excellent bioavailability and bone and joint concentrations. Ciprofloxacin can be used for sensitive gram-negative infections.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\u00bb Evidence is emerging that supports the use of oral antibiotics after 7 days of intravenous antibiotics for the treatment of PJI. Although this should be considered carefully, it can potentially alleviate the burden on patients and caregivers, with fewer intravenous lines and the potential for fewer complications.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:p>","DOI":"10.2106\/jbjs.rvw.19.00224","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T11:00:47Z","timestamp":1594378847000},"page":"e19.00224-e19.00224","source":"Crossref","is-referenced-by-count":45,"title":["Periprosthetic Joint Infection"],"prefix":"10.2106","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-5245","authenticated-orcid":false,"given":"Ryan","family":"Miller","sequence":"first","affiliation":[{"name":"Departments of Infectious Disease (R.M. and M.B.), Pharmacy (J.W.), and Orthopedic Surgery (A.K. and N.S.P.), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-2455","authenticated-orcid":false,"given":"Carlos A.","family":"Higuera","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Cleveland Clinic, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-2877","authenticated-orcid":false,"given":"Janet","family":"Wu","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease (R.M. and M.B.), Pharmacy (J.W.), and Orthopedic Surgery (A.K. and N.S.P.), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2755-0742","authenticated-orcid":false,"given":"Alison","family":"Klika","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease (R.M. and M.B.), Pharmacy (J.W.), and Orthopedic Surgery (A.K. and N.S.P.), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6421-9592","authenticated-orcid":false,"given":"Maja","family":"Babic","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease (R.M. and M.B.), Pharmacy (J.W.), and Orthopedic Surgery (A.K. and N.S.P.), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-7538","authenticated-orcid":false,"given":"Nicolas S.","family":"Piuzzi","sequence":"additional","affiliation":[{"name":"Departments of Infectious Disease (R.M. and M.B.), Pharmacy (J.W.), and Orthopedic Surgery (A.K. and N.S.P.), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7]]},"reference":[{"issue":"1","key":"r1-20230807","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cis966","article-title":"Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"r2-20230807","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.idc.2017.01.008","article-title":"Diagnosis of prosthetic joint infection: cultures, biomarker and criteria","volume":"31","author":"Gomez-Urena","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"r3-20230807","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arth.2012.02.022","article-title":"Economic burden of periprosthetic joint infection in the United States","volume":"27","author":"Kurtz","year":"2012","journal-title":"J Arthroplasty"},{"issue":"Suppl 1","key":"r4-20230807","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dku247","article-title":"Epidemiology and burden of prosthetic joint infections","volume":"69","author":"Lamagni","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"r6-20230807","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.joca.2016.12.010","article-title":"One-year incidence of prosthetic joint infection in total hip arthroplasty: a cohort study with linkage of the Danish Hip Arthroplasty Register and Danish microbiology databases","volume":"25","author":"Gundtoft","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"r7-20230807","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.arth.2015.03.035","article-title":"Quantifying the burden of revision total joint arthroplasty for periprosthetic infection","volume":"30","author":"Kamath","year":"2015","journal-title":"J Arthroplasty"},{"issue":"3","key":"r8-20230807","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12178-018-9513-0","article-title":"Current recommendations for the diagnosis of acute and chronic PJI for hip and knee-cell counts, alpha-defensin, leukocyte esterase, next-generation sequencing","volume":"11","author":"Goswami","year":"2018","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"16","key":"r9-20230807","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"r10-20230807","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","article-title":"The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria","volume":"33","author":"Parvizi","year":"2018","journal-title":"J Arthroplasty"},{"issue":"3","key":"r11-20230807","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmi.2018.04.035","article-title":"Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study","volume":"25","author":"Triffault-Fillit","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"r12-20230807","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cmi.2016.05.004","article-title":"REIPI (Spanish Network for Research in Infectious Disease) Group for the Study of Prosthetic Joint Infections. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study","volume":"22","author":"Benito","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"February","key":"r13-20230807","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.5435\/JAAOS-D-16-00639","article-title":"Microbiology and antimicrobial challenges of prosthetic joint infection","volume":"25","author":"Osmon","year":"2017","journal-title":"J Am Acad Orthop Surg"},{"issue":"Suppl 1","key":"r14-20230807","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/jac\/dku254","article-title":"Impact of bacterial biofilm on the treatment of prosthetic joint infections","volume":"69","author":"Jacqueline","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"r15-20230807","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"H\u00f8iby","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"r16-20230807","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11999-013-3016-5","article-title":"The Chitranjan Ranawat Award: should prophylactic antibiotics be withheld before revision surgery to obtain appropriate cultures?","volume":"472","author":"Tetreault","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"r17-20230807","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1302\/0301-620X.99B5.BJJ-2016-0851.R1","article-title":"High failure rates in treatment of streptococcal periprosthetic joint infection: results from a seven-year retrospective cohort study","volume":"99-B","author":"Akg\u00fcn","year":"2017","journal-title":"Bone Joint J"},{"issue":"9","key":"r18-20230807","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/JCM.00640-17","article-title":"The effect of preoperative antimicrobial prophylaxis on intraoperative culture results in patients with a suspected or confirmed prosthetic joint infection: a systematic review","volume":"55","author":"Wouthuyzen-Bakker","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"9","key":"r19-20230807","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.arth.2017.03.064","article-title":"Withholding preoperative antibiotic prophylaxis in knee prosthesis revision: a retrospective analysis on culture results and risk of infection","volume":"32","author":"Wouthuyzen-Bakker","year":"2017","journal-title":"J Arthroplasty"},{"issue":"2S","key":"r20-20230807","doi-asserted-by":"crossref","first-page":"S477","DOI":"10.1016\/j.arth.2018.09.033","article-title":"Hip and knee section, treatment, antimicrobials: proceedings of International Consensus on Orthopedic Infections","volume":"34","author":"de Beaubien","year":"2019","journal-title":"J Arthroplasty"},{"issue":"5","key":"r21-20230807","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5312\/wjo.v5.i5.667","article-title":"Treatment of acute periprosthetic infections with prosthesis retention: review of current concepts","volume":"5","author":"Kuiper","year":"2014","journal-title":"World J Orthop"},{"key":"r22-20230807","article-title":"A rare report of infectious emphysematous aortitis secondary to Clostridium septicum without prior vascular intervention","volume":"4984325","author":"Harris","year":"2017","journal-title":"Case Rep Vasc Med"},{"issue":"6","key":"r23-20230807","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/AAC.44.6.1616-1623.2000","article-title":"Phenotypic expression of oxacillin resistance in Staphylococcus epidermidis: roles of mecA transcriptional regulation and resistant-subpopulation selection","volume":"44","author":"Dickinson","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"r24-20230807","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch Intern Med"},{"issue":"38","key":"r25-20230807","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23380","article-title":"Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT","volume":"23","author":"Scarborough","year":"2019","journal-title":"Health Technol Assess"},{"issue":"7","key":"r26-20230807","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.arth.2017.02.057","article-title":"Oral therapy, microbiological findings, and comorbidity influence the outcome of prosthetic joint infections undergoing 2-stage exchange","volume":"32","author":"Ascione","year":"2017","journal-title":"J Arthroplasty"},{"issue":"4","key":"r27-20230807","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/CMR.00120-16","article-title":"The role of antibiotics in modulating virulence in Staphylococcus aureus","volume":"30","author":"Hodille","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"r28-20230807","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjmed.2015.09.006","article-title":"Clinical presentation, risk factors, and outcomes of hematogenous prosthetic joint infection in patients with Staphylococcus aureus bacteremia","volume":"129","author":"Tande","year":"2016","journal-title":"Am J Med"},{"issue":"2","key":"r29-20230807","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","article-title":"REIPI Group for the Study of Prosthetic Infection. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention","volume":"56","author":"Lora-Tamayo","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"r30-20230807","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijantimicag.2017.04.011","article-title":"Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus","volume":"51","author":"Wouthuyzen-Bakker","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"r31-20230807","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"5","key":"r32-20230807","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0924-8579(03)00006-2","article-title":"Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains","volume":"21","author":"Limoncu","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"r33-20230807","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(02)00369-9","article-title":"Fluoroquinolone resistance among gram-positive cocci","volume":"2","author":"Hooper","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"r34-20230807","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-62703-664-1_3","article-title":"Rapid methods for detection of MRSA in clinical specimens","volume":"1085","author":"Palavecino","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"51","key":"r35-20230807","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijid.2016.08.007","article-title":"Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis","volume":"51","author":"Lourtet-Hasco\u00ebt","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"6","key":"r36-20230807","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.3892\/etm.2017.4300","article-title":"Distribution characteristics of Staphylococcus spp. in different phases of periprosthetic joint infection: a review","volume":"13","author":"Guo","year":"2017","journal-title":"Exp Ther Med"},{"issue":"5","key":"r37-20230807","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(09)70066-0","article-title":"Gram-positive toxic shock syndromes","volume":"9","author":"Lappin","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"r38-20230807","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1542\/pir.32.10.423","article-title":"Group A streptococcal infections","volume":"32","author":"Langlois","year":"2011","journal-title":"Pediatr Rev"},{"issue":"6","key":"r39-20230807","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jemermed.2017.12.048","article-title":"The evaluation and management of toxic shock syndrome in the emergency department: a review of the literature","volume":"54","author":"Gottlieb","year":"2018","journal-title":"J Emerg Med"},{"issue":"1","key":"r40-20230807","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12879-016-1889-0","article-title":"G4 Bone and Joint Infection Study Group (G4BJIS). Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations","volume":"16","author":"Fiaux","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"12","key":"r41-20230807","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cix227","article-title":"Group of Investigators for Streptococcal Prosthetic Joint Infection. The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: the results of a large multicenter study","volume":"64","author":"Lora-Tamayo","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"r42-20230807","first-page":"269","article-title":"Clindamycin affects group a streptococcus virulence factors and improves clinical outcome","volume":"215","author":"Andreoni","year":"2017","journal-title":"J Infect Dis"},{"issue":"4","key":"r43-20230807","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/imj.12720","article-title":"Increasing clindamycin resistance among Australian group B Streptococcus isolates","volume":"45","author":"Chang","year":"2015","journal-title":"Intern Med J"},{"issue":"1","key":"r44-20230807","doi-asserted-by":"crossref","first-page":"ofv191","DOI":"10.1093\/ofid\/ofv191","article-title":"Characteristics and treatment outcomes of Propionibacterium acnes prosthetic shoulder infections in adults","volume":"3","author":"Piggott","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"r45-20230807","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/CMR.00092-13","article-title":"Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen","volume":"27","author":"Achermann","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"r46-20230807","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11420-016-9528-2","article-title":"Propionibacterium acnes host inflammatory response during periprosthetic infection is joint specific","volume":"13","author":"Nodzo","year":"2017","journal-title":"HSS J"},{"issue":"14","key":"r47-20230807","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2106\/JBJS.N.00881","article-title":"Early versus late culture growth of Propionibacterium acnes in revision shoulder arthroplasty","volume":"97","author":"Frangiamore","year":"2015","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"r48-20230807","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2106\/JBJS.M.00258","article-title":"Sensitivity of frozen section histology for identifying Propionibacterium acnes infections in revision shoulder arthroplasty","volume":"96","author":"Grosso","year":"2014","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"r49-20230807","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jse.2017.08.008","article-title":"Performance of implant sonication culture for the diagnosis of periprosthetic shoulder infection","volume":"27","author":"Grosso","year":"2018","journal-title":"J Shoulder Elbow Surg"},{"issue":"1","key":"r50-20230807","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2106\/JBJS.N.00104","article-title":"Synovial fluid interleukin-6 as a predictor of periprosthetic shoulder infection","volume":"97","author":"Frangiamore","year":"2015","journal-title":"J Bone Joint Surg Am"},{"issue":"11","key":"r51-20230807","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1469-0691.12721","article-title":"European Society Group of Infections on Artificial Implants (ESGIAI). Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study","volume":"20","author":"Tornero","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"r52-20230807","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.arth.2016.09.017","article-title":"Periprosthetic joint infections caused by enterococci have poor outcomes","volume":"32","author":"Kheir","year":"2017","journal-title":"J Arthroplasty"},{"issue":"2","key":"r53-20230807","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2016.02.006","article-title":"Vancomycin-resistant enterococci: therapeutic challenges in the 21st century","volume":"30","author":"Miller","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"r54-20230807","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"r55-20230807","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10096-019-03590-3","article-title":"Eravacycline, a newly approved fluorocycline","volume":"38","author":"Lee","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"r56-20230807","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"r57-20230807","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12879-017-2499-1","article-title":"Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature","volume":"17","author":"Swaminathan","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"4","key":"r58-20230807","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1345\/aph.1R604","article-title":"Serotonergic and adrenergic drug interactions associated with linezolid: a critical review and practical management approach","volume":"47","author":"Ramsey","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"5","key":"r59-20230807","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/OPX.0000000000001216","article-title":"Case report: linezolid optic neuropathy and proposed evidenced-based screening recommendation","volume":"95","author":"Dempsey","year":"2018","journal-title":"Optom Vis Sci"},{"issue":"5","key":"r60-20230807","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/jac\/dkv481","article-title":"Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention","volume":"71","author":"Tornero","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"r61-20230807","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/jbji.15722","article-title":"Pseudomonas prosthetic joint infections: a review of 102 episodes","volume":"1","author":"Shah","year":"2016","journal-title":"J Bone Jt Infect"},{"issue":"3","key":"r62-20230807","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mayocp.2014.12.002","article-title":"Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician","volume":"90","author":"Vasoo","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"r63-20230807","doi-asserted-by":"crossref","first-page":"O911","DOI":"10.1111\/1469-0691.12649","article-title":"REIPI Group for the Study of Prosthetic Infection. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study","volume":"20","author":"Rodr\u00edguez-Pardo","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"suppl_1","key":"r64-20230807","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"issue":"8","key":"r65-20230807","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14656566.2019.1594774","article-title":"Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections","volume":"20","author":"Mogle","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"15","key":"r66-20230807","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2106\/JBJS.N.00999","article-title":"Chronic suppression of periprosthetic joint infections with oral antibiotics increases infection-free survivorship","volume":"97","author":"Siqueira","year":"2015","journal-title":"J Bone Joint Surg Am"},{"issue":"63","key":"r67-20230807","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2017.08.002","article-title":"Antibiotic therapy duration for prosthetic joint infections treated by debridement and implant retention (DAIR): similar long-term remission for 6 weeks as compared to 12 weeks","volume":"63","author":"Chaussade","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"8","key":"r68-20230807","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/jac\/dkz202","article-title":"Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial","volume":"74","author":"Benkabouche","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"r69-20230807","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7150\/jbji.17353","article-title":"Efficacy of antibiotic suppressive therapy in patients with a prosthetic joint infection","volume":"2","author":"Wouthuyzen-Bakker","year":"2017","journal-title":"J Bone Jt Infect"},{"issue":"6","key":"r70-20230807","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7150\/jbji.37262","article-title":"Clinical Outcome of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection after Hip Replacement","volume":"4","author":"Leijtens","year":"2019","journal-title":"J Bone Jt Infect"},{"issue":"4","key":"r71-20230807","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0034-1376882","article-title":"Surgical management of periprosthetic joint infection: one-stage exchange","volume":"27","author":"Kendoff","year":"2014","journal-title":"J Knee Surg"},{"issue":"9","key":"r72-20230807","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s10096-017-2971-2","article-title":"Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study","volume":"36","author":"Prendki","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["JBJS Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.19.00224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:36:51Z","timestamp":1787751411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.RVW.19.00224"}},"subtitle":["A Review of Antibiotic Treatment"],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.rvw.19.00224","relation":{},"ISSN":["2329-9185"],"issn-type":[{"value":"2329-9185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}